A. S. Serikova

A. S. Serikova

Auto-generated profile, based on publicly available information

A. S. Serikova

Astana Medical University

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2024 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
IMI. Yu. Mukatova
I. Yu. Mukatova
ASA. S. Serikova
A. S. Serikova
GNG. S. Nuralieva
G. S. Nuralieva
SASergey Avdeev
Sergey Avdeev
Respiratory support for chronic respiratory failure in the last stages is widely used, most often in patients with end-stage COPD. It has been proven that the development of chronic hypercapnic respiratory failure is associated with an increasing in exacerbations, increased hospitalization rates, and an acceleration of the time before subsequent decompensation. Also hypercapnia isa determining factor in mortality. Effective treatment method of hypercapnic insufficiency is non-invasive ventilation. Long-term non-invasive ventilation improves daytime hypercapnia, quality of life, increases the period until the next severe exacerbation and survival of patients with COPD. Patients with COPD have different phenotypes and various comorbid diseases, which which may be challenging while choosing method of respiratory support and assessing the effectiveness of this treatment method. There is lack of data on long-term non-invasive respiratory support for patients with COPD after pneumonectomy in chronic period. Most of publications dedicated for early post-operative period after pneumonectomy. The purpose of this publication is to present a case of successful long-term non-invasive ventilation combined with oxygen therapy in a patient with COPD and bronchiectasis of a single lung. Stages of management of hypoxemic and subsequently developed hypercapnic chronic respiratory failure are reflected. We demonstrate experience of successful long-term ambulatory non-invasive ventilation in a patient with chronic hypercapnic respiratory failure as a result of COPD and pneumonectomy was demonstrated. Observation study showed feasibility of combined respiratory support in outpatient settings for patient with COPD of a single lung and a history of pneumonectomy.

22 June 2026 in PULMONOLOGIYA
Verified
Journal Article
Closed access
IMI. Yu. Mukatova
I. Yu. Mukatova
ASA. S. Serikova
A. S. Serikova
AVA. A. Vizel
A. A. Vizel
Sarcoidosis is a systemic inflammatory disease of unknown origin that can progress to fibrocavernous disease. Published data on antifibrotic therapy for fibrotic sarcoidosis are contradictory, largely due to an insufficient number of studies. In randomized trials, nintedanib has demonstrated efficacy in reducing the progression of interstitial lung disease; however, it has not shown a positive effect specifically in fibrotic sarcoidosis. Some individual studies have reported beneficial effects of antifibrotic therapy in cases of fibrotic sarcoidosis. Due to the limited and conflicting data, each observation of antifibrotic therapy in fibrotic sarcoidosis is valuable. The aim . Here, we describe our experience of using antifibrotic therapy in a patient with fibrotic pulmonary sarcoidosis. Methods . The patient, a 66-year-old woman with sarcoidosis-associated pulmonary fibrosis, has been receiving antifibrotic therapy (nintedanib 150 mg twice daily) since October 2022. Efficacy and safety were assessed before initiation and after 12, 24 and 32 months of antifibrotic therapy. Results . The respiratory deterioration slowed down, evidenced by an increased distance in the 6-minute walk test. Pulmonary function decline was also reduced, with no decrease in FEV 1 , FVC, FRC, or RV. Computed tomography scans revealed no progression in the volume of pulmonary fibrosis. Conclusion . The use of antifibrotic therapy was associated with stabilization of pulmonary function and no progression of pulmonary fibrosis. Further studies on antifibrotic therapy in fibrotic sarcoidosis are warranted.

14 July 2026 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
IMI. Yu. Mukatova
I. Yu. Mukatova
ASA. S. Serikova
A. S. Serikova
EAElena Amelina
Elena Amelina
GNG. S. Nuralieva
G. S. Nuralieva
Cystic fibrosis (CF) is an autosomal recessive monogenic hereditary disease characterized by dysfunction of the exocrine glands with damage to vital organs and systems, primarily the respiratory and digestive systems. Cystic fibrosis is associated with a reduction in life expectancy, the most common cause of death is progressive lung damage with the development of respiratory failure (RF). It is RF that most often determines the prognosis of CF, so timely diagnosis and correction of this complication is necessary. According to changes in the gas composition of arterial blood, there are 2 types of respiratory failure: hypoxemic and hypercapnic. Taking into account the types of RF, the type of respiratory support is determined: oxygen therapy and / or non-invasive ventilation (NIV). NIV has a positive effect on lung function, arterial blood gas parameters, body weight, duration and quality of life of patients with severe CF. Positive effects of NIV also include the effect of improving sputum drainage due to significant improvement of collateral ventilation. In recent years, due to the introduction of targeted therapy, the clinical picture of patients with CF has changed due to a decrease in the frequency of exacerbations of chronic bronchitis, improvement of functional indicators, and slowing down of the degradation of pulmonary function. However, the use of NIV in patients with CF remains relevant in cases where there is chronic hypercapnic respiratory failure, pronounced bronchopulmonary changes have formed in the form of widespread bronchiectasis, chronic, frequently recurring infectious process and pronounced impairment of sputum drainage. NIV is also indicated when targeted therapy cannot be prescribed due to the absence of corresponding mutations in the CFTR gene or if patients with CF do not have access to targeted therapy. In this regard, the accumulation of experience in NIV in patients with CF is an urgent task.

28 August 2025 in Наука и здравоохранение
Verified
Journal Article
Open access
ASA.S. Serikova
A.S. Serikova
IMI.Y. Mukatova
I.Y. Mukatova
SBS.A. Baidurin
S.A. Baidurin
ZUZh.M. Urazalina
Zh.M. Urazalina
Chronic respiratory failure (CRF) represents a common outcome of chronic bronchopulmonary diseases and significantly influences hospitalization rates, quality of life, and mortality. Improvement in patient prognosis depends not only on the management of the underlying disease but also on the targeted correction of CRF through various modalities of respiratory support, both during exacerbations and in remission phases. The principal strategies for respiratory support include oxygen therapy and non-invasive ventilation (NIV). The primary indication for long-term non-invasive ventilatory support is chronic hypercapnic respiratory failure. Prolonged use of NIV has been shown to improve pulmonary function, enhance gas exchange, increase exercise tolerance, reduce dyspnea, improve quality of life, decrease the risk of rehospitalization, and ultimately enhance survival. Currently, there is insufficient evidence regarding the initiation of non-invasive respiratory support in the outpatient setting for patients with chronic bronchopulmonary pathology. Only a limited number of studies with small cohorts have investigated home initiation of NIV in patients with hypercapnic CRF due to chronic obstructive pulmonary disease (COPD). These studies have demonstrated comparable efficacy in terms of arterial carbon dioxide levels when compared to in-hospital initiation. There is a clear need to expand research in this area by increasing sample sizes, which would allow for the development of evidence-based guidelines for outpatient NIV initiation. At present, there are no standardized recommendations regarding the timing of NIV initiation, patient selection criteria, or parameters for monitoring the effectiveness of non-invasive respiratory support in the ambulatory setting. Moreover, there is no consensus on evaluating the effectiveness of outpatient management of chronic hypercapnic respiratory failure. Thus, the development of clinical algorithms and evidence-based recommendations for the initiation, monitoring, and long-term management of patients receiving non-invasive ventilatory support in the outpatient setting remains a pressing issue. Хроническая дыхательная недостаточность (ХДН) является исходом хронических бронхолегочных заболеваний и определяет частоту госпитализаций, качество жизни и летальность. Улучшение прогноза пациентов обусловлено не только лечением основного заболевания, но и коррекцией непосредственно ХДН различными вариантами респираторной поддержки, как при обострении, так и в период ремиссии. Основные направления респираторной поддержки включают в себя применение кислородотерапии и неинвазивной вентиляции легких (НИВЛ). Показаниями для назначения длительной неинвазивной респираторной поддержки является хроническая гиперкапническая дыхательная недостаточность. Долгосрочная НИВЛ может улучшить функцию легких, газообмен, повысить толерантность к физическим нагрузкам, уменьшить одышку, улучшить качество жизни, снизить риск повторной госпитализации и повысить выживаемость. На сегодня, данных об инициации неинвазивной респираторной поддержки амбулаторно у пациентов с бронхолегочными заболеваниями недостаточно. Существуют единичные исследования с небольшим количеством пациентов с гиперкапнической ХДН на фоне ХОБЛ по началу неинвазивной респираторной поддержки в домашних условиях. Эти исследования продемонстрировали равнозначную эффективность с началом терапии в стационаре по уровню углекислого газа в артериальной крови. Необходимо расширение подобных исследований, увеличения группы наблюдения, что позволит создать рекомендации для инициации НИВЛ в амбулаторных условиях. На данный момент нет четких рекомендаций по срокам инициации НИВЛ, критериям отбора пациентов и контроля эффективности амбулаторной неинвазивной респираторной поддержки. Нет единой рекомендации по оценке эффективности хронической гиперкапнической дыхательной недостаточности на амбулаторном этапе. Актуальным является разработка алгоритмов и рекомендаций по инициации, контролю и ведению таких пациентов на амбулаторном этапе. Созылмалы тыныс жеткіліксіздігі (СТЖ) созылмалы бронхөкпелік аурулардың ақырғы кезеңі болып табылады және ол ауруханаға жатқызу жиілігін, өмір...

31 May 2026 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Closed access
GNG. S. Nuralieva
G. S. Nuralieva
ASAnna Shmidt
Anna Shmidt
VGVilya Gaynitdinova
Vilya Gaynitdinova
IAI. S. Avdeev
I. S. Avdeev
ASA. S. Serikova
A. S. Serikova
SASergey Avdeev
Sergey Avdeev
Kyphoscoliosis is a syndrome characterized by excessive curvature of the spine in the frontal and sagittal planes, which leads to impaired respiratory mechanics and respiratory failure. Kifoscolioz suffers about 1% of the population, but only in 10% of these cases there are significant clinical symptoms. Causes of chest deformation: idiopathic, congenital, deformations associated with neuromuscular diseases, acquired deformations. In the presence of chest deformation, there is often a serious impairment of lung function, which is likely caused by spinal curvature and compression of the chest cavity organs from the chest. These changes can lead to impaired movements of the diaphragm – the main respiratory muscle, resulting in a decrease in its efficiency. Changes in the position of the chest wall, reduced elasticity, and an unfavorable position of the respiratory muscles often lead to restrictive disorders of pulmonary ventilation. The pathogenesis of respiratory failure in patients with kyphoscoliosis is based on alveolar hypoventilation due to changes in the architecture of the chest and the structure of lung volumes, a decrease in respiratory effort during inspiration, a decrease in minute ventilation and hypoventilation during sleep. The aim of this study is to review the methods for correcting respiratory failure in patients with kyphoscoliosis, including surgical and conservative techniques, with a primary focus on respiratory support using non-invasive ventilation. The main conservative method of treating respiratory failure is respiratory support, namely noninvasive ventilation. This method can improve patient survival, normalize gas exchange, increase the efficiency of the respiratory muscles, improve the quality of sleep and life, and increase exercise tolerance.

22 June 2025 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
IMI. Yu. Mukatova
I. Yu. Mukatova
ABA. S. Belevskiy
A. S. Belevskiy
ASA. S. Serikova
A. S. Serikova
GNG. S. Nuralieva
G. S. Nuralieva
SASergey Avdeev
Sergey Avdeev
Obstructive sleep apnea is a condition characterized by snoring, periodic collapse of the upper respiratory tract at the level of the pharynx and cessation of pulmonary ventilation with continued respiratory efforts, decreased blood oxygen levels, gross fragmentation of sleep and excessive daytime sleepiness. Bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) remain a global problem for humanity due to persistent high levels of morbidity and mortality from these diseases. OSA is a common comorbid condition in many diseases, including chronic bronchopulmonary diseases such as BA, COPD and others, and always affects the course of these diseases. The presence of OSA in such patients is associated with disease progression, lack of disease control, frequent exacerbations, and an unfavorable outcome. This category of patients is difficult to treat with standard treatment and achieve disease control. This should be the key aspect in considering the appropriateness of diagnostics for obstructive sleep apnea syndrome. Despite the available data on the combination of OSA with chronic lung diseases, practitioners in most cases do not recognize this disease, and patients are left without full treatment. Timely detection and correction of OSA can reduce the frequency of hospitalizations, improve the course of BA and COPD, and reduce mortality. It is still relevant to conduct large population studies to identify the comorbidity of OSA in COPD and asthma, which will allow the development of algorithms for the early diagnosis of OSA with appropriate correction.